Get the Stockscreener App
1.54
1.99%
0.03
Pre-market:
1.57
0.03
+1.95%
Maxcyte Inc stock is traded at $1.54, with a volume of 757.03K.
It is up +1.99% in the last 24 hours and down -2.53% over the past month.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
See More
Previous Close:
$1.51
Open:
$1.49
24h Volume:
757.03K
Relative Volume:
0.91
Market Cap:
$164.17M
Revenue:
$45.44M
Net Income/Loss:
$-35.43M
P/E Ratio:
-4.5294
EPS:
-0.34
Net Cash Flow:
$-25.39M
1W Performance:
-5.52%
1M Performance:
-2.53%
6M Performance:
-45.77%
1Y Performance:
-56.98%
1-Day Range:
$1.49
$1.58
1-Week Range:
$1.49
$1.67
52-Week Range:
$1.26
$5.20
Maxcyte Inc Stock (MXCT) Company Profile
Name
Maxcyte Inc
Sector
Industry
Phone
301-517-5556
Address
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.54 | 160.98M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-22-25 | Initiated | Stephens | Overweight |
| Nov-29-23 | Initiated | Craig Hallum | Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-24-21 | Initiated | BTIG Research | Buy |
| Aug-24-21 | Initiated | Cowen | Outperform |
| Aug-24-21 | Initiated | Stephens | Overweight |
| Aug-24-21 | Initiated | Stifel | Buy |
| Aug-24-21 | Initiated | Wedbush | Outperform |
| Aug-24-21 | Initiated | William Blair | Outperform |
View All
Maxcyte Inc Stock (MXCT) Latest News
Will MaxCyte Inc. (MYE0) stock outperform benchmarksGlobal Markets & Entry Point Confirmation Signals - newser.com
What Wall Street predicts for MaxCyte Inc. stock priceBull Run & Safe Capital Growth Stock Tips - newser.com
Reversal indicators forming on MaxCyte Inc. stockEarnings Overview Report & Weekly Watchlist of Top Performers - newser.com
What MACD signals say about MaxCyte Inc.July 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Can MaxCyte Inc. stock deliver strong Q4 earningsMarket Rally & Entry Point Confirmation Alerts - newser.com
Is MaxCyte Inc. stock a buy in volatile marketsSwing Trade & Real-Time Market Sentiment Reports - newser.com
Will breakout in MaxCyte Inc. lead to full recovery2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
Why MaxCyte Inc. stock remains a top recommendation2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Statistical indicators supporting MaxCyte Inc.’s strength2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
Why MaxCyte Inc. stock could outperform in 2025July 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Backtesting results for MaxCyte Inc. trading strategiesJuly 2025 Selloffs & Fast Entry and Exit Trade Plans - newser.com
How to interpret RSI for MaxCyte Inc. stock2025 Big Picture & Growth Oriented Trade Recommendations - newser.com
Will MaxCyte Inc. (MYE0) stock see valuation expansion2025 Key Highlights & Smart Money Movement Alerts - newser.com
How buyback programs support MaxCyte Inc. (MYE0) stockDay Trade & AI Enhanced Execution Alerts - newser.com
Can MaxCyte Inc. stock resist market sell offsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
MaxCyte (MXCT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
MaxCyte, Inc. (NASDAQ:MXCT) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Technical analysis overview for MaxCyte Inc. stockShare Buyback & Consistent Return Strategy Ideas - newser.com
Maxcyte Inc Stock (MXCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Maxcyte Inc Stock (MXCT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Swirsky Douglas J | CHIEF FINANCIAL OFFICER |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
161,811 |
| Masoud Maher | President and CEO |
Aug 13 '25 |
Buy |
1.37 |
75,000 |
102,915 |
175,000 |
| Erck Stanley C | Director |
Aug 13 '25 |
Buy |
1.37 |
100,000 |
137,220 |
398,328 |
| DOUGLAS RICHARD | Director |
Aug 13 '25 |
Buy |
1.39 |
80,000 |
111,040 |
230,577 |
| Brooke William W | Director |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
150,879 |
0.34%
14.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):